Eli Lilly & Co ( (LLY) ) has issued an announcement.
Lucas Montarce has been appointed as the new executive vice president and chief financial officer of Eli Lilly and Company, bringing a wealth of experience from various finance leadership roles within the company since 2001. A successful executive with a proven track record in the pharmaceutical industry, Montarce steps into his new position with an annual salary of $1 million and an equal potential bonus, underlining Lilly’s commitment to leadership development and financial stability. His appointment comes without any pre-arranged agreements or family ties within the company, signaling a transparent and merit-based progression to this key executive role.
See more insights into LLY stock on TipRanks’ Stock Analysis page.
